臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

Jump to a point in the index:
Or type in a year:

Show Most Recent First

Ordering With Oldest First

Showing items 2234231-2234255 of 2346973 (93879 Page(s) Totally)
<< < 89365 89366 89367 89368 89369 89370 89371 89372 89373 89374 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-09-01T02:02:08Z	A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer	Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H.
臺大學術典藏	2021-09-01T02:02:09Z	Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Wang H.-P.; Lee J.-M.; Yeh K.-H.; Yang C.-H.; Lin J.-T.; ANN-LII CHENG; Lee Y.-C.
臺大學術典藏	2021-09-01T02:02:09Z	Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity	Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Kuo S.-H.; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:09Z	Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:10Z	Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma	Cheng T.-Y.; Lin J.-T.; Chen L.-T.; Shun C.-T.; Wang H.-P.; Lin M.-T.; Wang T.-E.; ANN-LII CHENG; Wu M.-S.
臺大學術典藏	2021-09-01T02:02:10Z	An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer	Chao Y.; Li C.P.; Chao T.Y.; Su W.C.; Hsieh R.K.; Wu M.F.; Yeh K.H.; Kao W.Y.; Chen L.T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:10Z	Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms	Lien H.-C.; Lu Y.-S.; ANN-LII CHENG; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; Chang K.-J.; Yao Y.-T.
臺大學術典藏	2021-09-01T02:02:11Z	Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis	Hsu C.; Shen Y.-C.; Cheng C.-C.; Hong R.-L.; Chang C.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:11Z	Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity	Lin C.-C.; Hsu C.-H.; Huang C.-Y.; ANN-LII CHENG; Chen J.; Vogelzang N.J.; Pu Y.-S.
臺大學術典藏	2021-09-01T02:02:12Z	Dramatic synergistic anticancer effect of clinically achievable doses of lovastatin and troglitazone	Yao C.-J.; Lai G.-M.; Chan C.-F.; ANN-LII CHENG; Yang Y.-Y.; Chuang S.-E.
臺大學術典藏	2021-09-01T02:02:12Z	Comparison of the expression and prognostic significance of differentiation markers between diffuse large B-cell lymphoma of central nervous system origin and peripheral nodal origin	Lin C.-H.; Kuo K.-T.; Chuang S.-S.; Kuo S.-H.; Chang J.H.; Chang K.-C.; Hsu H.-C.; Tien H.-F.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:12Z	Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa	Lu Y.-S.; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:12Z	A pathway for tumor necrosis factor-α-induced Bcl10 nuclear translocation: Bcl10 is up-regulated by NF-κB and phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus	Pei Y.Y.; Kuo S.-H.; Yeh K.-H.; Chuang S.-E.; Hsu C.-H.; Wen C.C.; Lin H.-I.; Gao M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:13Z	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2021-09-01T02:02:13Z	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Shiah H.-S.; ANN-LII CHENG; Hsu C.; Hsu C.-H.; Liu T.-W.; Chang J.-Y.; Jan C.-M.; Chao Y.; Yu W.-L.; Chuang T.-R.; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2021-09-01T02:02:13Z	Primary thyroid lymphoma mimicking subacute thyroiditis [4]	Yang Y.-S.; Wu M.-Z.; ANN-LII CHENG; Chang T.-C.
臺大學術典藏	2021-09-01T02:02:14Z	Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors	Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Yeh K.-H.; Kuo M.-L.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:14Z	Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients	Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J.
臺大學術典藏	2021-09-01T02:02:15Z	Inhibitors of epidermoid growth factor receptor suppress cell growth and enhance chemosensitivity of nasopharyngeal cancer cells in vitro	Hsu C.-H.; Gao M.; Chen C.-L.; Yeh P.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:15Z	Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma	Chen L.-T.; Lin J.-T.; Tai J.J.; Chen G.-H.; Yeh H.-Z.; Yang S.-S.; Wang H.-P.; Kuo S.-H.; Sheu B.-S.; Jan C.-M.; Wang W.-M.; Wang T.-E.; Wu C.-W.; Chen C.-L.; Su I.-J.; Whang-Peng J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:15Z	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment	Yang C.-H.; Chen M.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Yu Y.-C.; Whang-Peng J.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:15Z	Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer	Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Lin J.-F.; Hsu C.; Kuo S.-H.; Li Jr. S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:16Z	Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications from age-period-cohort analysis	Shen Y.-C.; Chang C.-J.; Hsu C.; Cheng C.-C.; Chiu C.-F.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:16Z	Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung	Yeh K.-H.; Yeh S.-H.; Wan J.-P.; Shen Y.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:16Z	Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21 )	Yeh K.-H.; Kuo S.-H.; Chen L.-T.; Mao T.-L.; Doong S.-L.; Wu M.-S.; Hsu H.-C.; Tzeng Y.-S.; Chen C.-L.; Lin J.-T.; ANN-LII CHENG

Showing items 2234231-2234255 of 2346973 (93879 Page(s) Totally)
<< < 89365 89366 89367 89368 89369 89370 89371 89372 89373 89374 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :2854037
	Visitors : 45325847 Online Users : 787 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library